Premium
AATOD white paper details how OTPs and buprenorphine providers can collaborate
Publication year - 2016
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30148
Subject(s) - buprenorphine , opioid use disorder , opioid , closing (real estate) , medicine , opiate substitution treatment , business , receptor , finance
A new report from the American Association for the Treatment of Opioid Dependence (AATOD) focuses on how opioid treatment programs (OTPs) can collaborate with other health care providers, including office‐based buprenorphine prescribers, on closing the treatment gap for opioid use disorders.